Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Working towards novel albuminuria endpoints in chronic kidney disease.

Fernandez-Fernandez B, Sanchez-Niño MD, Ortiz A.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):80-82. doi: 10.1016/S2213-8587(18)30352-8. Epub 2019 Jan 8. No abstract available.

PMID:
30635227
2.

Albuminuria: all you need to predict outcomes in chronic kidney disease?

Gansevoort RT, Nauta FL, Bakker SJ.

Curr Opin Nephrol Hypertens. 2010 Nov;19(6):513-8. doi: 10.1097/MNH.0b013e32833e4ce1. Review.

PMID:
20802333
3.

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials.

Heerspink HJL, Greene T, Tighiouart H, Gansevoort RT, Coresh J, Simon AL, Chan TM, Hou FF, Lewis JB, Locatelli F, Praga M, Schena FP, Levey AS, Inker LA; Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):128-139. doi: 10.1016/S2213-8587(18)30314-0. Epub 2019 Jan 8.

PMID:
30635226
4.

Surrogate endpoints in clinical trials of chronic kidney disease progression: moving from single to multiple risk marker response scores.

Schievink B, Mol PG, Lambers Heerspink HJ.

Curr Opin Nephrol Hypertens. 2015 Nov;24(6):492-7. doi: 10.1097/MNH.0000000000000159. Review.

PMID:
26335552
5.

High-normal albuminuria and incident chronic kidney disease in a male nondiabetic population.

Ashitani A, Ueno T, Nakashima A, Doi S, Yamane K, Masaki T.

Clin Exp Nephrol. 2018 Aug;22(4):835-842. doi: 10.1007/s10157-017-1522-6. Epub 2017 Dec 26.

PMID:
29280046
6.

Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial.

Heerspink HJ, Ninomiya T, Persson F, Brenner BM, Brunel P, Chaturvedi N, Desai AS, Haffner SM, Mcmurray JJ, Solomon SD, Pfeffer MA, Parving HH, de Zeeuw D.

Diabetes Obes Metab. 2016 Feb;18(2):169-77. doi: 10.1111/dom.12600. Epub 2016 Jan 13.

PMID:
26511599
7.

Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement.

Johnson DW, Jones GR, Mathew TH, Ludlow MJ, Chadban SJ, Usherwood T, Polkinghorne K, Colagiuri S, Jerums G, Macisaac R, Martin H; Australasian Proteinuria Consensus Working Group.

Med J Aust. 2012 Aug 20;197(4):224-5.

PMID:
22900872
8.

Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.

Tanaka N, Babazono T, Takagi M, Yoshida N, Toya K, Nyumura I, Hanai K, Uchigata Y.

Nephrology (Carlton). 2015 Aug;20(8):531-8. doi: 10.1111/nep.12446.

PMID:
25773273
9.

Chronic nitric oxide deficiency and progression of kidney disease after renal mass reduction in the C57Bl6 mouse.

Muller V, Tain YL, Croker B, Baylis C.

Am J Nephrol. 2010;32(6):575-80. doi: 10.1159/000322106. Epub 2010 Nov 11.

10.

Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP).

Chang TI, Li S, Chen SC, Peralta CA, Shlipak MG, Fried LF, Whaley-Connell AT, McCullough PA, Kurella Tamura M; KEEP Investigators.

Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S4-11. doi: 10.1053/j.ajkd.2012.12.016.

11.

Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review.

Levey AS, Becker C, Inker LA.

JAMA. 2015 Feb 24;313(8):837-46. doi: 10.1001/jama.2015.0602. Review.

12.

Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease.

Suliman ME, Yilmaz MI, Carrero JJ, Qureshi AR, Saglam M, Ipcioglu OM, Yenicesu M, Tong M, Heimbürger O, Barany P, Alvestrand A, Lindholm B, Stenvinkel P.

Clin J Am Soc Nephrol. 2008 Jul;3(4):976-85. doi: 10.2215/CJN.03960907. Epub 2008 Apr 16.

13.
14.

The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis.

Dumanski SM, Ramesh S, James MT, Metcalfe A, Nerenberg K, Seely EW, Robertson HL, Ahmed SB.

Syst Rev. 2017 Jul 7;6(1):134. doi: 10.1186/s13643-017-0519-2.

15.

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127. doi: 10.1016/S2213-8587(18)30313-9. Epub 2019 Jan 8.

PMID:
30635225
17.

Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria.

Pulido-Olmo H, García-Prieto CF, Álvarez-Llamas G, Barderas MG, Vivanco F, Aranguez I, Somoza B, Segura J, Kreutz R, Fernández-Alfonso MS, Ruilope LM, Ruiz-Hurtado G.

Clin Sci (Lond). 2016 Apr 1;130(7):525-38. doi: 10.1042/CS20150517. Epub 2016 Jan 5.

PMID:
26733721
18.

Prevalence of chronic kidney disease in China: a cross-sectional survey.

Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H.

Lancet. 2012 Mar 3;379(9818):815-22. doi: 10.1016/S0140-6736(12)60033-6. Erratum in: Lancet. 2012 Aug 18;380(9842):650.

PMID:
22386035
19.

The kidney and cardiovascular outcome trials.

Bloomgarden Z.

J Diabetes. 2018 Feb;10(2):88-89. doi: 10.1111/1753-0407.12616.

PMID:
29031006
20.

Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes.

De Cosmo S, Rossi MC, Pellegrini F, Lucisano G, Bacci S, Gentile S, Ceriello A, Russo G, Nicolucci A, Giorda C, Viazzi F, Pontremoli R; AMD-Annals Study Group.

Nephrol Dial Transplant. 2014 Mar;29(3):657-62. doi: 10.1093/ndt/gft506. Epub 2014 Jan 6.

Supplemental Content

Support Center